Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials

BackgroundCancer treatment-induced bone loss (CTIBL) is a frequent complication of breast cancer therapies affecting both disability and health-related quality of life (HRQoL). To date, there is still a lack of consensus about the most effective approach that would improve bone health and HRQoL. The...

Full description

Bibliographic Details
Main Authors: Alessandro de Sire, Lorenzo Lippi, Konstantinos Venetis, Stefania Morganti, Elham Sajjadi, Claudio Curci, Antonio Ammendolia, Carmen Criscitiello, Nicola Fusco, Marco Invernizzi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.829875/full